A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Purpose An optimal target for glucose control in ICU patients remains unclear. This prospective randomized controlled trial compared the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control. Methods Adult patients admitted to the 21 participating medico-surgical ICUs were randomized to group 1 (target BG 7.8-10.0 mmol/L) or to group 2 (target BG 4.4-6.1 mmol/L). Results While the required sample size was 1,750 per group, the trial was stopped early due to a high rate of unintended protocol violations. From 1,101 admissions, the outcomes of 542 patients assigned to group 1 and 536 of group 2 were analysed. The groups were well balanced. BG levels averaged in group 1 8.0 mmol/L (IQR 7.1-9.0) (median of all values) and 7.7 mmol/L (IQR 6.7-8.8) (median of morning BG) versus 6.5 mmol/L (IQR 6.0-7.2) and 6.1 mmol/L (IQR 5.5-6.8) for group 2 (p Conclusions In this prematurely stopped and therefore underpowered study, there was a lack of clinical benefit of intensive insulin therapy (target 4.4-6.1 mmol/L), associated with an increased incidence of hypoglycaemia, as compared to a 7.8-10.0 mmol/L target. (ClinicalTrials.gov # NCT00107601, EUDRA-CT Number: 200400391440).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A retrospective study suggested that tidal volumes should be lowered even with plateau pressures ≤ 30 cm H 2 O (431) because lower plateau pressures were associated with reduced hospital mortality (432).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [431]
In the citing paper
“In the surgical ICU, earlier studies have indicated that intensive glucose control (80 to 110 mg/dL) inconsistently resulted in decreased length of stay.94–96”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Intensive glycemic control post-operatively, compared to less intensive targets, has resulted in equivocal or mixed results; however, other studies have shown no benefits.94,100,101,104”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [94]
In the citing paper
“Obese patients are only slightly more prevalent in the ICU than in the hospital and in the related populations.”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
In the citing paper
“There is a large variability in the prevalence between countries with more than 39% and 37% obese (BMI>30 kg/m 2 ) present in the US ICUs and hospital wards, 22% and 19% in Europe, 17% and 14% in South America and 10% and 7% in the Asian and Pacific region based on data from the Nutrition Day project (6,351).”
From ESPEN guideline on clinical nutrition in the intensive care unit. (2019) · cites this paper as [351]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“The Acute Physiological and Chronic Health Evaluation (APACHE II) on admission [11] and the daily Sequential Organ Failure Assessment (SOFA) [12] scores and the presence of diabetes were recorded.”
MethodVincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674 · cited 9×
“The overall severity of organ failures assessed by daily SOFA scores were similar in both groups as were the other severity indices of illness, the number of febrile days and the number of days with anti-infective agents, except for the number of patient days with vasopressors/inotropes which was higher in the group 2…”
MethodInfluentialIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119 · cited 1×
“Nevertheless, the mortality was slightly and not significantly increased in the group 2, consistently with other recent prospective trials [7, 14, 18, 19].”
ResultIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 9×
“The proportion of time in range calculated from morning BG values was not lower than in the most of the other studies [6, 7, 13, 17].”
BackgroundMethodResultInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Riker, R. R. (2009) · JAMA · doi:10.1001/jama.2009.56 · Cited by 1,672
Dungan, K. M., Braithwaite, S. S., & Preiser, J.-C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60553-5 · Cited by 1,431
Self-citationKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“with other recent findings [14, 25].”
Research works printed but not linked: 2
- Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol study. Intensive Care Med 33:S189
- Devos P, Ledoux D, Preiser JC (2005) Current practice of glycaemia control in European intensive care units (ICUS). Intensive Care Med 31:S203
Cited by
Items 301–400 of 912
Pilot Study of the SPRINT Glycemic Control Protocol in a Hungarian Medical Intensive Care Unit
Benyó, B. I., Illyés, A., Némedi, N. S., Compte, A. J. L., Havas, A., Kovács, L., Fisk, L., Shaw, G. M., & Chase, J. G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600628 · Cited by 26
Guan, X., Chen, D., & Xu, Y. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.12.002 · Cited by 28
“Evidence summary: One recent meta-analysis [ 214 ] (57 RCTs, [ 203–210 ] n = 21,840) showed that ICU patients who received tight glycemic control had a significantly lower all-cause mortality rate (OR = 0.89, 95% CI: 0.80 to 1.00, I 2 = 32%; P = 0.04), a lower rate of infection (OR = 0.65, 95% CI:…”
BackgroundInfluentialThe Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024
Shime, N., Nakada, T., Yatabe, T., Yamakawa, K., Aoki, Y., Inoue, S., Iba, T., Ogura, H., Kawai, Y., Kawaguchi, A., et al. (2025) · Acute Medicine & Surgery · doi:10.1002/ams2.70037 · Cited by 27
The Glycemic Ratio Is Strongly and Independently Associated With Mortality in the Critically Ill
Roberts, G., Krinsley, J. S., Preiser, J., Quinn, S. J., Rule, P. R., Brownlee, M., Schwartz, M. W., Umpierrez, G. E., & Hirsch, I. B. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221124114 · Cited by 25
Self-citationHeung, M., & Koyner, J. L. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.004 · Cited by 24
Mulla, I., Schmidt, K., Cashy, J., Wallia, A., Andrei, A., Oakes, D. J., Aleppo, G., Li, C., Grady, K. L., McGee, E. C., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1199 · Cited by 24
Assessing Inpatient Glycemic Control: What are the Next Steps?
Cook, C. B., Wellik, K. E., Kongable, G. L., & Shu, J. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600230 · Cited by 28
Is intensive insulin therapy the scapegoat for or cause of hypoglycaemia and poor outcome?
Uyttendaele, V., Knopp, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2019) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2019.100063 · Cited by 25
Should inpatient hyperglycaemia be treated?
Dhatariya, K. (2013) · BMJ · doi:10.1136/bmj.f134 · Cited by 28
Sachwani, G. R., Jaehne, A. K., Jayaprakash, N., Kuzich, M., Onkoba, V., Blyden, D., & Rivers, E. P. (2016) · Journal of Inflammation · doi:10.1186/s12950-016-0122-7 · Cited by 24
What’s new in glucose control in the ICU?
den Berghe, G. V. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2874-3 · Cited by 24
Trends in glycemic control over a 2‐year period in 126 US hospitals
Bersoux, S., Cook, C. B., Kongable, G. L., & Shu, J. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.1997 · Cited by 23
Masla, M., Gottschalk, A., Durieux, M. E., & Groves, D. S. (2010) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2010.09.028 · Cited by 26
Stewart, K. W., Pretty, C. G., Tomlinson, H., Fisk, L., Shaw, G. M., & Chase, J. G. (2014) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2014.09.011 · Cited by 24
“2 mmol/L (4-5 patients) were lower than any reported study, where rates of 10-20% by patient have been reported [17, 45, 46].”
BackgroundKadoi, Y. (2010) · Journal of Anesthesia · doi:10.1007/s00540-010-0988-0 · Cited by 23
“The Glucontrol study from Europe in 2009 [ 17 ] had to be discontinued because the rate of hypoglycemia was higher in the intensive insulin therapy group (8.7%) than in the conventional insulin therapy group (2.7%, P \ 0.0001).”
InfluentialGarcia, C., Wallia, A., Gupta, S., Schmidt, K., Malekar‐Raikar, S., Oakes, D. J., Aleppo, G., Grady, K., McGee, E. C., Cotts, W., et al. (2013) · Clinical Transplantation · doi:10.1111/ctr.12118 · Cited by 23
“Black 16 (17) 2 (8) 14 (21) NS Asian 4 (4) 2 (8) 2 (3) NS Hispanic 4 (4) 0 (0) 4 (6) NS Other 1 (1) 0 (0) 1 (2) Cardiac indication for transplant Ischemic CM 35 (38) 13 (50) 22 (33) NS Dilated CM 23 (25) 4 (15) 19 (73) NS Non-ischemic CM 9 (10) 3 (12) 6 (9) NS”
ResultHerpe, T. V., Moor, B. D., den Berghe, G. V., & Mesotten, D. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.227017 · Cited by 26
The Long and Winding Road Toward Personalized Glycemic Control in the Critically Ill
Krinsley, J. S. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817728299 · Cited by 23
Ethyl pyruvate is renoprotective against ischemia-reperfusion injury under hyperglycemia
Jun, J. H., Song, J. W., Shin, E.-J., Kwak, Y. L., Choi, N., & Shim, J. (2017) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2017.10.069 · Cited by 23
Kapoor, R., Timsina, L., Gupta, N., Kaur, H., Vidger, A. J., Pollander, A. M., Jacobi, J., Khare, S., & Rahman, O. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113635 · Cited by 23
“The NICE-SUGAR study and meta-analysis linked intensive blood sugar control (<110 mg/dL) with hypoglycemia and higher mortality [9,10].”
MethodManual versus Automated moNitoring Accuracy of GlucosE II (MANAGE II)
Shinotsuka, C. R., Brasseur, A., Fagnoul, D., So, T., Vincent, J., & Preiser, J. (2016) · Critical Care · doi:10.1186/s13054-016-1547-3 · Cited by 23
“[5] was not confirmed in later multicenter trials [4, 6–8].”
Self-citationHonarmand, K., Sirimaturos, M., Hirshberg, E. L., Bircher, N. G., Agus, M. S. D., Carpenter, D. L., Downs, C. R., Farrington, E. A., Freire, A. X., Grow, A., et al. (2024) · Critical Care Medicine · doi:10.1097/ccm.0000000000006173 · Cited by 22
Self-citationCampion, T. R., May, A. K., Waitman, L. R., Özdaş, A., Lorenzi, N. M., & Gadd, C. S. (2011) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000129 · Cited by 22
“Intensive insulin therapy (IIT) is the standard of critical care, but recent studies questioned the treatment's mortality benefit and safety.”
BackgroundWhat is the optimal blood glucose target in critically ill patients? A nested cohort study
Arabi, Y. M., Al-Tarifi, A., Abou‐Shala, N., Tamim, H., & Rishu, A. (2011) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.84774 · Cited by 22
“In contrast, the Glucontrol[17] and NICE-SUGAR[14] studies used lower targets for the conventional insulin therapy group [<10 mmol/L (<180 mg/dL)].”
Use Of Incretin-Based Therapy in Hospitalized Patients with Hyperglycemia
Umpierrez, G. E., & Schwartz, S. S. (2014) · Endocrine Practice · doi:10.4158/ep13471.ra · Cited by 22
Wernly, B., Lichtenauer, M., Franz, M., Kabisch, B., Muessig, J. M., Masyuk, M., Kelm, M., Hoppe, U. C., & Jung, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091586 · Cited by 22
“Whereas in the early 2000s tight glucose control in septic patients was thought to be beneficial, it could be shown in large, prospective trials that intensive glucose control is even detrimental for these patients [11–13].”
BackgroundImproving Postdischarge Outcomes in Acute Heart Failure
Chioncel, O. D., Collins, S. P., Ambrosy, A. P., Pang, P. S., Antohi, E., Iliescu, V. A., Maggioni, A. P., Butler, J., & Mebazaa, A. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000791 · Cited by 22
“However the most adequate strategy for glucose control in AHF patients is not known, since tight glucose control, investigated in GLUCONTROL (67) and NICE-SUGAR (68), was not associated with improved outcomes in critically ill patients.”
Intensive Glycemic Control in Cardiac Surgery
Tsai, L. L., Jensen, H., & Thourani, V. H. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0719-5 · Cited by 25
Hypoglycemia in the Critically Ill: How Low Is Too Low?
Krinsley, J. S., & Keegan, M. T. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0010 · Cited by 22
Umpierrez, G. E. (2023) · New England Journal of Medicine · doi:10.1056/nejme2309442 · Cited by 21
Novel insights in endocrine and metabolic pathways in sepsis and gaps for future research
Téblick, A., Gunst, J., Langouche, L., & den Berghe, G. V. (2022) · Clinical Science · doi:10.1042/cs20211003 · Cited by 24
Association between hyperglycemia and adverse clinical outcomes of sepsis patients with diabetes
Lin, S., Lai, D., & He, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1046736 · Cited by 22
Chase, J. G., Desaive, T., & Preiser, J.-C. (2016) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-319-27349-5_35 · Cited by 24
Self-citationWernly, B., Jirak, P., Lichtenauer, M., Franz, M., Kabisch, B., Schulze, P. C., Braun, K., Muessig, J. M., Masyuk, M., Paulweber, B., et al. (2018) · Medical Principles and Practice · doi:10.1159/000496205 · Cited by 21
An Update on Nutrition Support in the Critically Ill
Gerlach, A. T., & Murphy, C. V. (2010) · Journal of Pharmacy Practice · doi:10.1177/0897190010388142 · Cited by 22
“In fact one study was terminated early due to protocol violations.(66) In all these studies, the eugylcemia groups were more likely to develop hypoglycemia and one had a significantly Gerlach and Murphy 73”
BackgroundUnderstanding glycemic control in the critically ill: three domains are better than one
Krinsley, J. S. (2011) · Intensive Care Medicine · doi:10.1007/s00134-010-2110-3 · Cited by 21
“studies [6, 7] were terminated prematurely by their safety”
BackgroundThe Future is Now: Software-Guided Intensive Insulin Therapy in the Critically Ill
Rattan, R., & Nasraway, S. A. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700231 · Cited by 22
What, why and how to monitor blood glucose in critically ill patients
Juneja, D., Deepak, D., & Nasa, P. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.528 · Cited by 22
Wang, Y., Li, S., Lu, J., Feng, K., Huang, X., Hu, F., Sun, M., Zou, Y., Li, Y., Huang, W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06136-1 · Cited by 23
“The present results suggest that critically ill patients with sensor glucose level exceeding 10.5 mmol/l (190 mg/dl) may have an increased risk of mortality, similar to the findings of some previous RCTs targeting different blood glucose ranges [4–6].”
InfluentialComparison of Insulin Infusion Protocols Targeting 110–140 mg/dL in Patients After Cardiac Surgery
Magaji, V., Nayak, S., Donihi, A. C., Willard, L. A., Jampana, S., Nivedita, P., Eder, R., Johnston, J., & Korytkowski, M. T. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0114 · Cited by 21
Agus, M. S. D., Hirshberg, E. L., Srinivasan, V., Faustino, E. V. S., Luckett, P. M., Curley, M. A. Q., Alexander, J. L., Asaro, L. A., Coughlin-Wells, K., Duva, D., et al. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.12.023 · Cited by 20
Zhu, C., Chen, J., Pan, J., Qiu, Z., & Xu, T. (2018) · Medicine · doi:10.1097/md.0000000000011671 · Cited by 23
“observations can be found in general patients as well as those with traumatic brain injury (TBI).([2,3]) Typically, TBI will lead to profoundly increased glucose utilization (also known as hyper-”
BackgroundNaderi-Behdani, F., Heydari, F., Ala, S., Moradi, S., Abediankenari, S., Asgarirad, H., & Khodabakhsh, E. (2022) · PubMed Central · doi:10.22088/cjim.13.1.51 · Cited by 22
“Unfortunately, attempts to overcome SIH could induce hypoglycemia that is associated with high mortality rate (7-9).”
BackgroundTrauma and Aggressive Homeostasis Management
Neligan, P. J., & Baranov, D. Y. (2012) · Anesthesiology Clinics · doi:10.1016/j.anclin.2012.10.007 · Cited by 23
Finfer, S. R. (2013) · Virulence · doi:10.4161/viru.25855 · Cited by 21
Second pilot trials of the STAR-Liege protocol for tight glycemic control in critically ill patients
Penning, S., Compte, A. J. L., Massion, P. B., Moorhead, K. T., Pretty, C. G., Preiser, J., Shaw, G. M., Suhaimi, F. M., Desaive, T., & Chase, J. G. (2012) · BioMedical Engineering OnLine · doi:10.1186/1475-925x-11-58 · Cited by 20
Self-citationClinical benefits of tight glycaemic control: Focus on the perioperative setting
Furnary, A. P. (2009) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2009.10.001 · Cited by 20
Drazen, J. M. (2012) · New England Journal of Medicine · doi:10.1056/nejme1207121 · Cited by 21
Kraft, R., Herndon, D. N., Mlcak, R. P., Finnerty, C. C., Cox, R. A., Williams, F. N., & Jeschke, M. G. (2013) · Burns · doi:10.1016/j.burns.2013.07.007 · Cited by 19
“[29] as well as the Sepsis guidelines are to achieve intermediate systemic glucose levels of 140 mg/dl [27].”
Suitability of Capillary Blood Glucose Analysis in Patients Receiving Vasopressors
Ellis, M. F., Benjamin, K., Cornell, M. S., Decker, K., Farrell, D., McGugan, L., Porter, G. P., Shearin, H., Zhao, Y., & Granger, B. B. (2013) · American Journal of Critical Care · doi:10.4037/ajcc2013692 · Cited by 19
Critical care of burn patients. New approaches to old problems
Lavrentieva, A. (2015) · Burns · doi:10.1016/j.burns.2015.04.009 · Cited by 23
Bouw, J. W., Campbell, N. L., Hull, M. A., Juneja, R., Guzman, O., & Overholser, B. R. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0130 · Cited by 19
“19 Although the American Diabetes Association has updated treatment guidelines regarding intensive insulin treatment in the ICU to include a more lenient range of glucose control compared with this study, there is continued debate about the appropriate target range for ICU patients.”
Prevention of ventilator-associated pneumonia in adults
Prescott, H. C., & O’Brien, J. M. (2010) · F1000 Medicine Reports · doi:10.3410/m2-15 · Cited by 19
“However, intensive insulin regimens have been increasingly scrutinized as new data suggesting their potential for harm emerge [28-30].”
BackgroundDuncan, A. E., Sessler, D. I., Sato, H., Sato, T., Nakazawa, K., Carvalho, G., Hatzakorzian, R., Codère-Maruyama, T., Abd-Elsayed, A. A., Bose, S., et al. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002156 · Cited by 20
Glucose Control in the Intensive Care Unit: A Nutrition Support Perspective
Krenitsky, J. (2011) · Nutrition in Clinical Practice · doi:10.1177/0884533610392237 · Cited by 20
Impacto do controle glicêmico intensivo na lesão renal aguda: ensaio clínico randomizado
Santos, E. S., Kanke, P. H., Vieira, R. D. C. A., de Oliveira, L. B., Ferretti‐Rebustini, R. E. D. L., de Menezes, A. F., Barreto, Í. D. D. C., & Hajjar, L. A. (2019) · Acta Paulista de Enfermagem · doi:10.1590/1982-0194201900083 · Cited by 20
Maternal Sepsis: A Review of National and International Guidelines
Stephens, A. J., Chauhan, S. P., Barton, J. R., & Sibai, B. M. (2021) · American Journal of Perinatology · doi:10.1055/s-0041-1736382 · Cited by 23
Xia, W., Li, C., Kuang, M., Wu, Y., Xu, L., & Hu, H. W. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03278-z · Cited by 18
“One possible explanation could be an intensive glucose-lowering treatment can markedly increase the risk of hypoglycemia, the strict glycemic control strategies are proven to have neutral or even deleterious effects on cardiovascular outcomes in diabetic critically ill patients [37, 47, 48].”
BackgroundZhao, Y., Wu, Y., & Xiang, B. (2018) · Pediatric Research · doi:10.1038/s41390-018-0002-3 · Cited by 18
Interpretation of Retrospective BG Measurements
Stewart, K. W., Pretty, C. G., Shaw, G. M., & Chase, J. G. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818786518 · Cited by 18
Wintergerst, K. A., Foster, M. B., Sullivan, J. E., & Woods, C. R. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600102 · Cited by 18
Plummer, M. P., Notkina, N., Timofeev, I. S., Hutchinson, P. J., Finnis, M., & Gupta, A. K. (2018) · Critical Care · doi:10.1186/s13054-017-1933-5 · Cited by 21
Year in review 2009: Critical Care - metabolism
Huberlant, V., & Preiser, J. (2010) · Critical Care · doi:10.1186/cc9256 · Cited by 19
“Clinical management of glucose control Th e failure to reproduce the results of the Leuven I study [1] in diff erent settings, including two large-scale prospective randomised international trials published in 2009 [ 14 ,15], raised a number of important issues directly relevant to daily practice [16].”
ResultSelf-citationPretty, C. G. (2012) · UC Research Repository (University of Canterbury) · doi:10.26021/2015 · Cited by 23
Signal, M., Thomas, F., Shaw, G. M., & Chase, J. G. (2013) · Journal of Diabetes Science and Technology · doi:10.1177/193229681300700609 · Cited by 17
Nurse- vs Nomogram-Directed Glucose Control in a Cardiovascular Intensive Care Unit
Chant, C. A., Mustard, M., Thorpe, K. E., & Friedrich, J. O. (2012) · American Journal of Critical Care · doi:10.4037/ajcc2012713 · Cited by 17
Blood glucose control in 2010: 110 to 150 mg/dL and minimal variability*
Vincent, J. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181d16b2e · Cited by 18
Intensive insulin therapy during cardiovascular surgery
Kawahito, S., Kitahata, H., Kitagawa, T., & Oshita, S. (2010) · The Journal of Medical Investigation · doi:10.2152/jmi.57.191 · Cited by 18
Daily Evolution of Insulin Sensitivity Variability with Respect to Diagnosis in the Critically Ill
Ferenci, T., Benyó, B. I., Kovács, L., Fisk, L., Shaw, G. M., & Chase, J. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057119 · Cited by 20
“[21]).”
Knopp, J. L., Lynn, A. M., Shaw, G. M., & Chase, J. G. (2018) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2017-314072 · Cited by 17
Nutrition delivery, workload and performance in a model-based ICU glycaemic control system
Stewart, K. W., Chase, J. G., Pretty, C. G., & Shaw, G. M. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.09.005 · Cited by 17
Computerized Insulin Infusion Programs Are Safe and Effective in the Burn Intensive Care Unit
Lee, J. G., Fortlage, D. A., Box, K. W., Sakarafus, L., Bhavsar, D., Coimbra, R. S. M., & Potenza, B. M. (2011) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e3182331e39 · Cited by 17
“17,18 Maintaining this range has been challenging because of the nature of the care given to the burn patient.”
BackgroundMargonis, G. A., Amini, N., Sasaki, K., Kim, Y., Merath, K., Buettner, S., Pikoulis, E. A., Andreatos, N., Wagner, D., Antoniou, E., et al. (2016) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-016-3278-9 · Cited by 18
“Furthermore, aggressive treatment of severe hyperglycemia may even place critically ill patients at increased risk for serious adverse events related to hypoglycemia.(13,14) In fact, according to the NICE-SUGAR study, intensive glucose control increased mortality among adults in the ICU.”
Hersh, A. M., Hirshberg, E. L., Wilson, E. L., Orme, J. F., Morris, A. H., & Lanspa, M. J. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.04.025 · Cited by 18
“6% (Table 1).(1,4,5,7-15) Numerous studies have suggested a strong relationship between severe hypoglycemia and subsequent mortality,(6,16-19) and it is possible that the higher rates of severe hypoglycemia uniformly seen in the intervention arms may have obscured beneficial effects of IIT.”
BackgroundBIAGAS, K. V., Hinton, V. J., Hasbani, N. R., Luckett, P. M., Wypij, D., Nadkarni, V., Agus, M. S. D., Srinivasan, V., Mourani, P. M., Chima, R. S., et al. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.10.055 · Cited by 16
Insulin sensitivity in critically ill patients: are women more insulin resistant?
Uyttendaele, V., Chase, J. G., Knopp, J. L., Gottlieb, R., Shaw, G. M., & Desaive, T. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00807-7 · Cited by 16
“Monte Carlo simulations analysis Although the proportions in this cohort reflects what is typically seen in general ICUs and are similar to those in large randomised trials [4, 8, 9], Monte Carlo simulations were used to account and reduce bias from unbalanced sexes and T2DM cohort proportions.”
MethodInsulin resistance in critical illness: consequences for nutrition therapy and glucose management
Gunst, J., & Verbruggen, S. C. A. T. (2023) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001055 · Cited by 18
Abdelmalak, B., Maheshwari, A., Kovaci, B., Mascha, E. J., Cywiński, J. B., Kurz, A. M., Kashyap, V. S., & Sessler, D. I. (2011) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-011-9509-3 · Cited by 16
“Indeed, tight glucose control goals in critical care units have resulted in unacceptably high rates of hypoglycemia(9,12) and increased mortality.(8)”
BackgroundWallia, A., Gupta, S., Garcia, C., Schmidt, K., Oakes, D. J., Aleppo, G., Glossop, V., Andrei, A., Grady, K. L., McGee, E. C., et al. (2013) · Endocrine Practice · doi:10.4158/ep13354.or · Cited by 16
Current management of sepsis in critically ill adult patients
Vincent, J., Serrano, E. C., & Dimoula, A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.65 · Cited by 23
Impact of perioperative hypoglycaemia in subjects with diabetes undergoing colorectal surgery
Goh, S. S. N., Yeoh, E. C. K., & Tan, K. Y. (2016) · International Journal of Colorectal Disease · doi:10.1007/s00384-016-2680-9 · Cited by 17
Antonelli, M. M., Azoulay, É., Bonten, M. J. M., Chastre, J. E., Citerio, G., Conti, G., Backer, D. D., Lemaire, F., Gerlach, H., Hedenstierna, G., et al. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1781-0 · Cited by 16
“Preiser and Coll [114] published a prospective randomized controlled trial comparing the effects on ICU mortality of intensive insulin therapy (IIT) with an intermediate glucose control.”
BackgroundSelf-citationTraversing the valley of glycemic control despair
Chase, J. G., & Dickson, J. L. (2017) · Critical Care · doi:10.1186/s13054-017-1824-9 · Cited by 16
Ma, H., Qian, X., Song, X., Jiang, R., Li, J., Fang, X., Dou, R., Guan, X., Lui, K. Y., Li, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1610519 · Cited by 15
Kobeissy, F. H. (2015) · CRC Press eBooks · doi:10.1201/b18126-32 · Cited by 15
Kumar, S. S., Pelletier, S. J., Shanks, A. M., Leis, A. M., Sonnenday, C. J., & Picton, P. (2020) · BMC Anesthesiology · doi:10.1186/s12871-019-0918-0 · Cited by 16
Analytic Review: Glucose Controversies in the ICU
Honiden, S., & Inzucchi, S. E. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610387892 · Cited by 17
Dickerson, R. N., Johnson, J. L., Maish, G. O., Minard, G., & Brown, R. O. (2012) · Nutrition · doi:10.1016/j.nut.2012.01.010 · Cited by 15
“The European Glucontrol intravenous RHI infusion trial was discontinued prematurely because of its numerous protocol violations and high occurrence of severe hypoglycemia [16].”
BackgroundZabolotskikh, I. B., Кirov, М. Y., Лебединский, К. М., Николаевич, П. Д., Avdeev, S. N., Andreenko, A. A., Arsentev, L. V., Афончиков, В. С., Игоревич, А. И., Belkin, A. A., et al. (2020) · Annals of critical care · doi:10.21320/1818-474x-2020-s1-9-120 · Cited by 17
Naraba, H., Goto, T., Shirakawa, T., Sonoo, T., Kanda, N., Nakano, H., Takahashi, Y., Hashimoto, H., & Nakamura, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252158 · Cited by 15
“Hypoglycemia presents an independent risk of death, as well as risks of convulsions and arrhythmias [24, 25].”
BackgroundInsulin Infusion Therapy in Critically Ill Patients
Boutin, J., & Gauthier, L. (2014) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2014.01.016 · Cited by 17
Spence, C. J. (2015) · ACM International Conference on Interactive Tabletops and Surfaces (ITS) · doi:10.1145/2817721.2817924 · Cited by 15
Which factors influence glycemic control in the intensive care unit?
Preiser, J., Devos, P., & Chioléro, R. L. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328335720b · Cited by 16
Self-citationDiabetes - Damages and Treatments
Rigobelo, E. C. (2011) · InTech eBooks · doi:10.5772/1823 · Cited by 17
Biolo, G., Massolino, B., Girolamo, F. G. D., Fiotti, N., Mearelli, F., Mazzucco, S., Bertuzzi, C. A., Lazzarini, R., Colombatti, A., & Cicco, M. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190291 · Cited by 15
Updates in Glycemic Management in the Hospital
Mongkolpun, W., Provenzano, B. C., & Preiser, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1274-7 · Cited by 16
Self-citationAlonso, C. V., Carmona, T. G., & Díaz, M. J. (2011) · PubMed · doi:10.1590/s0212-16112011000800010 · Cited by 15
Feng, M., & Zhou, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-55504-9 · Cited by 16
“Previous studies have calculated mean blood glucose without considering the time interval of blood glucose measurement, and have set fixed glycemia control targets for both conventional and intensive glycemia control groups 3,7,9–11 .”
Wieske, L., Harmsen, R. E., Schultz, M. J., & Horn, J. (2011) · Neurocritical Care · doi:10.1007/s12028-011-9507-x · Cited by 14
Papak, J., & Kansagara, D. L. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.08.034 · Cited by 15
Metadata
- Authors
- Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., Wernerman, J., Joannidis, M., Stecher, A., & Chioléro, R.
- Affiliations
- Centre Hospitalier Universitaire de Liège (BE)
- Erasmus Hospital (BE)
- Hôpital Raymond-Poincaré (FR)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- University of Milan (IT)
- Université Joseph Fourier (FR)
- Institut Gustave Roussy (FR)
- Rabin Medical Center (IL)
- Karolinska Institutet (SE)
- Universität Innsbruck (AT)
- Ljubljana University Medical Centre (SI)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Preiser, Jean-Charles
- ORCID
- Venue
- Intensive Care Medicine
- Published
- 2009-07-28
- Volume
- 35
- Issue
- 10
- Pages
- 1738-1748
- ISSN
- 0342-4642 (ISSN-L)
- 1432-1238
- OpenAlex
- W2139706988
- Cited by
- 911
- References
- 37
- Citations by year
- 2026: 16 · 2025: 15 · 2024: 24 · 2023: 33 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 48 · 2018: 48 · 2017: 46 · 2016: 57 · 2015: 69 · 2014: 80 · 2013: 76 · 2012: 95
- FWCI
- 75.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Intensive Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- Acceda (Universidad de Las Palmas de Gran Canaria) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Universidad de Las Palmas de Gran Canaria
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Keywords
- intensive insulin therapy, tight glycemic control, glycemic targets, critically ill adults, intensive care unit, ICU mortality, hypoglycemia, insulin therapy, early trial termination, protocol violations, time in target glucose range, ICU length of stay, cost-effectiveness, quality of life
- MeSH terms
- Aged, Blood Glucose, Female, Humans, Hyperglycemia, Hypoglycemic Agents, Insulin, Intensive Care Units, Male, Middle Aged, Prospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.